P. Bonniaud (Dijon, France), E. Bargagli (Siena, Italy), A. Torrego (Barcelona, Spain), P. Spagnolo (Liestal, Switzerland)
LATE-BREAKING ABSTRACT: Epidemiology of IPF in Italy
S. Harari, F. Madotto, A. Caminati, S. Conti, G. Cesana (Via San Vittore 12, Milano, Via Bicocca degli Arcimboldi 8, Milano, Italy)
|   |
Atypical variants of clinical course of sarcoidosis
V. Romanov (Moscow, Russian Federation)
| |
Types of interstitial lung diseases and comparison on survival of idiopathic and secondary types in a tertiary care setting of Sri Lanka
A. Upul, D. Dasanayake, K. Wickramasekara, L. Gamage, A. Siribaddana (Kandy, Sri Lanka)
| |
Translation and preliminary validation of the KBILD QOL questionnaire to Spanish
G. Cotta Ramusino, I. Martin-Robles, D. Castillo, S. Birring (Barcelona, Spain; London, United Kingdom)
| |
PROOF-registry: A prospective observational registry to describe the disease course and outcomes of idiopathic pulmonary fibrosis patients in a real-world clinical setting
W. Wuyts, C. Dahlqvist, M. Schlesser, C. Compere, H. Slabbynck, B. Bondue, M. Berrens, C. Giot, P. DeVuyst (Leuven, Yvoir, Liège, Antwerpen, Brussels, Belgium; Luxembourg, Luxembourg; Nieuwegein, Netherlands; Muttenz, Switzerland)
| |
A Phase 2, double-blind, placebo-controlled study of N–acetylcysteine in combination with pirfenidone in patients with idiopathic pulmonary fibrosis
J. Behr, E. Bendstrup, B. Crestani, A. Günther, H. Olschewski, M. Skoeld, A. Wells, W. Wuyts, H. Tang, J. Beck, C. Albera (Munich, Giessen, Germany; Aarhus C, Denmark; Paris, France; Graz, Austria; Stockholm, Sweden; London, United Kingdom; Leuven, Belgium; Brisbane, United States Of America; Muttenz, Switzerland; Orbassano (Turin), Italy)
| |
Idiopathic pulmonary fibrosis is associated with a preferential alteration of kCO rather than of DLCO
J. Pastre, C. Delclaux, S. Roussel, K. Juvin, J. Valcke, D. Israel-Biet (Paris, France)
| |
Long-term effects of nebulized LPS in a mouse model of acute lung injury (ALI)
N. Costa, M. Veras, G. Ribeiro Júnior, A. Alemany, M. Dolhnikoff, L. F. Silva (São Paulo, Brazil)
| |
Morality predictors in acute exacerbation of idiopathic pulmonary fibrosis
G. Dabar, M. Iskandar, B. Habr, Z. Aoun, M. Riachy, G. Khayat (Beirut, Lebanon)
| |
Heat shock proteins as 'danger signals' in sarcoidosis
A. Dubaniewicz (Gdansk, Poland)
| |
Pirfenidone in diffuse parenchymal lung disease after stem cell transplantation of a patient with dyskeratosis congenita
M. Rosewich, O. Eickmeier, J. Eckrich, R. Schubert, S. Zieen (Frankfurt/M, Germany)
| |
Clinical profile and early follow-up of patients receiving pirfenidone in the PIONEER observational study
R. Dhar, K. S. Satish, S. Rajan, R. Vijai Kumar, Z. Udwadia, H. Dumra, M. Mohan, R. Namjoshi, N. Ghag, J. Gogtay (Kolkata, Bengaluru, Mumbai, Hyderabad, Ahmedabad, India)
| |
Multiple segmental lavage in the treatment of pulmonary alveolar proteinosis
Y. Ilkovich, L. Novikova, A. Bazhanov (St. Petersburg, Russian Federation)
| |
Does hypoxemia increases risks in hospitalized patients with diffuse interstitial lung disease?
E. Demirdogen Cetinoglu, A. Gorek Dilektasli, E. Uzaslan, A. Ursavas, E. Ege (Bursa, Turkey)
| |
Amphetamine induced eosinophilic pneumonia: A case report
K. Rososinska, S. Henschke, M. Reichert, R. Bals (Homburg/Saar, Germany)
| |
Clinical data, lung function and cardiopulmonary exercise testing in CPFE (combined pulmonary fibrosis with emphysema). Results of a cohort of 20 patients
M. Westhoff, P. Litterst (Hemer, Germany)
| |
Serum levels of sestrin 2 in patients with sarcoidosis
A. Roussou, A. Papaioannou, E. Manali, A. Spathis, N. Pianou, A. Georgakopoulos, J. Tomos, A. Karakatsani, K. Kostikas, S. Chatziioannou, P. Karakitsos, S. Papiris (Athens, Greece)
| |
6MWT performance by means of Spiropalm in patients affected by fibrotic idiopathic interstitial pneumonias: Preliminary observations
M. Bocchino, R. Cobuccio, M. De Martino, G. Rea, A. Matarese, A. Canora, C. Vitale, A. A. Stanziola, A. Sanduzzi (Naples, Italy)
| |
Secondary organizing pneumonia (BOOP)-associated with granulomatosis with polyangiitis [Wegener granulomatosis (WG)]: A clinicoradiological study of 19 cases
F. S. Oymak, S. Balkanli, O. Oymak (Kayseri, Turkey)
| |
Fibrosis in emphysema: Radiologically occult but histologically prevalent process proportionate to smoking burden
A. Fabre, N. Faheem, J. Dodd, M. Narski, A. Treacy, D. Healy, I. Lawrie, T. Finucane, M. Keane, J. Egan, M. Tolan, G. Jebrak, H. Mal, M. Butler (Dublin, Ireland; Paris, France)
| |